Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that it has secured three further orders totalling over $1m in the CBRN detection segment.
This includes two orders in nuclear security, with one order for the further development of the Group’s bio-security technology. The majority of the revenue will be recognised in the current financial year, which helps to underpin forecasts along with the recent $5.9m contract from the US Department of Homeland Security.
